FR Doc 04-7026

[Federal Register: March 30, 2004 (Volume 69, Number 61)]
[Notices]
[Page 16542-16545]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr30mr04-67]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

Enhancing Cancer Prevention and Control Programs for American
Indian/Alaska Native Women

Announcement Type: New.
Funding Opportunity Number: PA 04144.
Catalog of Federal Domestic Assistance Number: 93.283.
Key Dates:
Letter of Intent Deadline: April 20, 2004.
Application Deadline: May 14, 2004.

I. Funding Opportunity Description Authority

This program is authorized under sections 301(a), 317(k)(2) of the
Public Health Service Act [42 U.S.C. 241(a) and 247b(k)(2)], as
amended.
Purpose: The purpose of the program is to enhance the capacity of
tribal and state National Breast and Cervical Cancer Early Detection
Program (NBCCEDP) and/or National Comprehensive Cancer Control Program
(CCC) grantees to serve the largest possible number of eligible
American Indian/Alaska Native (AI/AN) women. The successful applicant
should be able to identify culturally appropriate approaches and
implementation strategies to address the national scope of this program
announcement. This program addresses the ``Healthy People 2010'' focus
area of cancer.
Measurable outcomes of the program will be in alignment with one
(or more) of the following performance goal(s) for the National Center
for Chronic Disease Prevention and Health Promotion (NCCDPHP): (1)
Increase early detection of breast and cervical cancer by building
nationwide programs in breast and cervical cancer prevention especially
among high risk, underserved women; (2) Expand community-based breast
and cervical cancer screening and diagnostic services to low income,
medically underserved women; (3) Assure access to treatment services
for women diagnosed with cancer or pre-cancer.

Activities

Awardee activities related to this program are as follows:
Identify culturally appropriate approaches that
tribal NBCCEDP grantees can use to increase screening to underserved
rarely, or never screened, AI/AN women through the following means:

--Identify approaches and implementation strategies that tribal Program
Directors can use to increase culturally appropriate health care
delivery and cultural sensitivity for all cooperative agreement
grantees through annual trainings, workshops, and conferences.
--Identify approaches and implementation strategies for tribal Program
Directors to integrate Cancer Programs into the tribal health care
system.
--Provide culturally appropriate management and leadership skills
training to tribal program staff.
--Identify and implement national communication strategies among tribal
grantees.
--Identify effective culturally appropriate mentoring strategies that
can be used by tribal grantees to improve program performance.
--Identify and disseminate effective intervention strategies to other
Breast and Cervical tribal grantees.
--In collaboration with CDC staff, participate in a bi-annual training,
as needed, on Tribal Outreach Strategies.
--Identify program implementation strategies that can be used by tribal
CCC grantees to develop coalitions to strengthen their comprehensive
control plans.

Identify approaches and implementation
strategies for state NBCCEDP grantees to increase screening to
underserved, rarely or never screened AI/AN women through the following
means:

--Assist state Program Directors to develop effective and appropriate
partnerships with tribes.
--Identify opportunities to conduct combined meetings with states and
tribes/tribal organizations within those states to develop realistic
and culturally sensitive approaches for screening women.
--Identify opportunities to develop partnerships between Urban Indian
Health Clinics and state Breast and Cervical Cancer Early Detection
Programs in collaboration with CDC staff.
--Disseminate information and best practices through annual meetings,
workshops and appropriate venues for all cooperative agreement
grantees.
--Identify training opportunities for states to develop outreach
strategies to reach AI/AN women for breast and cervical cancer
screening.
--Identify strategies to engage AI/AN people in the development of
state coalitions CCC plans.

In a cooperative agreement, CDC staff is substantially involved in
the program activities, above and beyond routine grant monitoring.
CDC Activities for this program are as follows:
Assist in developing and planning annual
trainings, workshops, and conferences designed to disseminate
information and increase culturally appropriate health care delivery
and cultural sensitivity for all cooperative agreement grantees.
Assist in the development of and review all
cancer training materials to ensure that the materials are based on AI/
AN learning styles and are science based.
Assist in identifying and setting priorities for
Leadership Training curriculum for tribal grantees.
Develop strategies and methods to assist the
grantee in evaluating the impact of the grantee's activities.
Assist in annual dissemination of information
through annual workshops, meetings, and other appropriate venues
designed to increase culturally appropriate health care delivery and
cultural sensitivity for all cooperative agreement grantees.

II. Award Information

Type of Award: Cooperative Agreement.
CDC involvement in this program is listed in the Activities Section
above.
Fiscal Year Funds: 2004.
Approximate Total Funding: $400,000.

[[Page 16543]]

Approximate Number of Awards: 1.
Approximate Average Award: $400,000 (This amount is for the first
12-month budget period, and includes both direct and indirect costs).
Floor of Award Range: None.
Ceiling of Award Range: $400,000.
Anticipated Award Date: September 30, 2004.
Budget Period Length: 12 months.
Project Period Length: 3 years.
Throughout the project period, CDC's commitment to continuation of
awards will be conditioned on the availability of funds, evidence of
satisfactory progress by the recipient (as documented in required
reports), and the determination that continued funding is in the best
interest of the Federal Government.

III. Eligibility Information

III.1. Eligible applicants

Applications may be submitted by public and private nonprofit
organizations, such as:
Public nonprofit organizations
Private nonprofit organizations
Faith-based organizations

III.2. Cost Sharing or Matching

Matching funds are not required for this program.

III.3. Other

CDC will accept and review applications with budgets greater than
the ceiling of the award range.
If your application is incomplete or non-responsive to the
requirements listed in this section, it will not be entered into the
review process. You will be notified that your application did not meet
submission requirements.
Applicants should have extensive experience assisting AI/AN tribes,
tribal organizations, health departments and populations with the
management of women health care programs, including breast and cervical
cancer early detection program activities. Therefore, eligible
organizations should:
Have staff in key positions with 5 or more years
of relevant experience.
Provide proof of nonprofit status; see AR-15 for
additional detail.
Demonstrate extensive experience with unique
health service delivery issues for American Indian/Alaska Native women,
and experience in working with IHS, tribes, tribal organizations, and
state staff to identify effective strategies to deliver culturally
competent breast and cervical cancer screening services to this
population.
Demonstrate success in providing technical
assistance to states to increase their cancer screening of AI/AN women.

Note: Title 2 of the United States Code section 1611 states that
an organization described in section 501(c)(4) of the Internal
Revenue Code (Title 26) that engages in lobbying activities is not
eligible to receive Federal funds constituting an award, grant, or
loan.

IV. Application and Submission Information

IV.1. Address To Request Application Package

To apply for this funding opportunity use application form PHS
5161. Application forms and instructions are available on the CDC Web
site, at the following Internet address: http://www.cdc.gov/od/pgo/forminfo.htm
.

If you do not have access to the Internet, or if you have
difficulty accessing the forms on-line, you may contact the CDC
Procurement and Grants Office Technical Information Management Section
(PGO-TIM) staff at: (770) 488-2700. Application forms can be mailed to
you.

IV.2. Content and Form of Submission

Letter of Intent (LOI): Your LOI must be written in the following
format:
Maximum number of pages: 2.
Font size: 12-point unreduced
Single spaced
Paper size: 8.5 by 11 inches
Page margin size: One inch
Printed only on one side of page
Written in plain language, avoid jargon
Your LOI must contain the following information:
Name of organization
Contact information
Application: You must submit a project narrative with your
application forms. The narrative must be submitted in the following
format:
Maximum number of pages: 20. If your narrative
exceeds the page limit, only the first pages which are within the page
limit will be reviewed.
Double spaced
Font size: 12 point unreduced
Paper size: 8.5 by 11 inches
Page margin size: One inch
Printed only on one side of page
Held together only by rubber bands or metal
clips; not bound in any other way.
Your narrative should address activities to be conducted over the
entire project period, and must include the following items in the
order listed:
1. Executive Summary
The applicant should provide a clear, concise 1-2 page written
summary to include:
Rationale for this approach to technical
assistance versus another approach.
Priority areas for technical assistance.
Activities and the experience of the staff to
provide culturally sensitive training and technical assistance.
Identification of the major activities proposed
to develop or implement a technical assistance/ training program.
Requested amount of Federal funding.
Applicant's capability to conduct the
activities.
2. Background
The applicant should describe:
The unique technical assistance needs of urban/
rural population needing screening.
The unique technical assistance needs of States
with large breast and cervical cancer unscreened populations.
Relevant experiences in development and
implementation of tribal/state health department screening programs.
Relevant experiences in coordination and
collaboration between and among existing programs.
Existing initiatives, capacity, and
infrastructure within which AI/AN screening will occur.
3. Management Plan
Submit a management plan that includes a
description of proposed management structure, organizational chart,
internal and external communication systems and a system for sound
fiscal management.
Provide a description of the proposed or
existing linkages with IHS, state health departments and national AI/AN
organizations.
Provide (in the appendices) curriculum vitae and
job descriptions of all staff funded through this announcement.
Provide a detailed work plan that describes how
the activities will be carried out. It should include the following:

--Goals and objectives for Year 01
--Activities planned to achieve objectives
--Data that will be used to assess program activities
--Time line for assessing progress
--The person or persons responsible for activities and overall measures
of effectiveness. These measures must be objective/quantitative and
must measure the intended outcome.
4. Itemized Budget and Justification
A detailed budget with supporting justification
must be provided and should be related to objectives that are stated in
the applicant's work plan.
Additional information may be included in the application
appendices.

[[Page 16544]]

The appendices will not be counted toward the narrative page limit.
This additional information includes:
Organizational Charts
Letters of Support
You are required to have a Dun and Bradstreet Data Universal
Numbering System (DUNS) number to apply for a grant or cooperative
agreement from the Federal Government. The DUNS number is a nine-digit
identification number, which uniquely identifies business entities.
Obtaining a DUNS number is easy and there is no charge. To obtain a
DUNS number, access http://www.dunandbradstreet.com or call 1 (866) 705-5711.

For more information, see the CDC Web site at: http://www.cdc.gov/od/pgo/funding/pubcommt.htm
.

If your application form does not have a DUNS number field, please
write your DUNS number at the top of the first page of your
application, and/or include your DUNS number in your application cover
letter.
Additional requirements that may require you to submit additional
documentation with your application are listed in section ``VI.2.
Administrative and National Policy Requirements.''

IV.3. Submission Dates and Times

LOI Deadline Date: April 20, 2004.
CDC requests that you send a LOI if you intend to apply for this
program. Although the LOI is not required, not binding, and does not
enter into the review of your subsequent application, the LOI will be
used to gauge the level of interest in this program, and to allow CDC
to plan the application review.
Application Deadline Date: May 14, 2004.
Explanation of Deadlines: Applications must be received in the CDC
Procurement and Grants Office by 4 p.m. Eastern Time on the deadline
date. If you send your application by the United States Postal Service
or commercial delivery service, you must ensure that the carrier will
be able to guarantee delivery of the application by the closing date
and time. If CDC receives your application after closing due to: (1)
Carrier error, when the carrier accepted the package with a guarantee
for delivery by the closing date and time, or (2) significant weather
delays or natural disasters, you will be given the opportunity to
submit documentation of the carriers guarantee. If the documentation
verifies a carrier problem, CDC will consider the application as having
been received by the deadline.
This announcement is the definitive guide on application submission
address and deadline. It supersedes information provided in the
application instructions. If your application does not meet the
deadline above, it will not be eligible for review, and will be
discarded. You will be notified that your application did not meet the
submission requirements.
CDC will not notify you upon receipt of your application. If you
have a question about the receipt of your application, first contact
your courier. If you still have a question, contact the PGO-TIM staff
at: (770) 488-2700. Before calling, please wait two to three days after
the application deadline. This will allow time for applications to be
processed and logged.

IV.4. Intergovernmental Review of Applications

Executive Order 12372 does not apply to this program.

IV.5. Funding Restrictions

Restrictions, which must be taken into account while writing your
budget, are as follows:
Awards will not allow reimbursement of pre-award
costs.
If you are requesting indirect costs in your budget, you must
include a copy of your indirect cost rate agreement. If your indirect
cost rate is a provisional rate, the agreement should be less than 12
months of age.
Guidance for completing your budget can be found on the CDC Web
site, at the following Internet address: http://www.cdc.gov/od/pgo/

funding/budgetguide.htm.

IV.6. Other Submission Requirements

LOI Submission Address: Submit your LOI by express mail, delivery
service, fax, or E-mail to:

Annie Voigt, Program Consultant, Centers for Disease Control and
Prevention, National Center for Chronic Disease Prevention and Health
Promotion, Division of Cancer Prevention and Control, Program Services
Branch.

For mail service:

4770 Buford Highway, NE., Mailstop K-57, Atlanta, GA 30341-3724.

For delivery service:

2858 Woodcock Blvd, Davidson Building, Room 2059, Chamblee, GA
30341, telephone (770) 488-4707, fax (770) 488-3230, e-mail:
anv1@cdc.gov.

Application Submission Address: Submit the original and two hard
copies of your application by mail or express delivery service to:

Technical Information Management--PA 04144, CDC
Procurement and Grants Office, 2920 Brandywine Road, Atlanta, GA 30341.

Applications may not be submitted electronically at this time.

V. Application Review Information

V.1. Criteria

You are required to provide measures of effectiveness that will
demonstrate the accomplishment of the various identified objectives of
the cooperative agreement. Measures of effectiveness must relate to the
performance goals stated in the ``Purpose'' section of this
announcement. Measures must be objective and quantitative, and must
measure the intended outcome. These measures of effectiveness must be
submitted with the application and will be an element of evaluation.
Your application will be evaluated against the following criteria:
1. Work Plan (40 Points)
Is the plan adequate to carry out the proposed activities,
including how the applicant plans to work collaboratively with other
organizations and individuals who may have an impact on breast and
cervical cancer prevention and control objectives? Are the goal(s)
clear, objectives specific, measurable, achievable, realistic and time-
phased? Are the activities clear and specific?
2. Management Plan (30 Points)
Does the organization have the organizational capacity and program
management skills and experience to develop and manage the program? Are
proposed staff qualified and do they possess capacity to perform the
technical assistance described? Does staff have expertise working with
AI/AN populations in the management of women's health care programs,
including breast and cervical cancer early detection program
activities?
3. Evaluation Plan (20 Points)
Will the evaluation plan monitor both the progress toward meeting
project objectives and their impact?
4. Background (10 Points)
Does the application identify the: (1) Limitations of access in
both urban and rural populations, (2) need for culturally appropriate
technical assistance and training for tribal grantees, and (3)
difficulty for states to reach AI/AN women for cancer screening and to
find AI/AN women to serve on coalitions and planning committees?
5. Budget
Is each line-item budget and narrative justification reasonable and
consistent

[[Page 16545]]

with the purpose and objectives of the program? (Not weighted)

V.2. Review and Selection Process

Applications will be reviewed for completeness by the Procurement
and Grants Office (PGO) staff, and for responsiveness by NCCDPHP.
Incomplete applications and applications that are non-responsive to the
eligibility criteria will not advance through the review process.
Applicants will be notified that their application did not meet
submission requirements.
An objective review panel will evaluate complete and responsive
applications according to the criteria listed in the ``V.1. Criteria''
section above.
In addition, the following factors may affect funding the funding
decision:
Demonstrated success in securing AI/AN staff, (including
consultants) who are from, or have worked in and are familiar with,
each of the 12 Indian Health Service Areas and who have served key
roles in the health care systems and activities of tribal health
departments, Indian Health Boards, Inter-tribal Councils and/or Indian
Health Service.

V.3. Anticipated Announcement and Award Dates

September 30, 2004.

VI. Award Administration Information

VI.1. Award Notices

Successful applicants will receive a Notice of Grant Award (NGA)
from the CDC Procurement and Grants Office. The NGA shall be the only
binding, authorizing document between the recipient and CDC. The NGA
will be signed by an authorized Grants Management Officer, and mailed
to the recipient fiscal officer identified in the application.
Unsuccessful applicants will receive notification of the results of the
application review by mail.

VI.2. Administrative and National Policy Requirements

45 CFR Part 74 and Part 92
For more information on the Code of Federal Regulations, see the
National Archives and Records Administration at the following Internet
address: http://www.access.gpo.gov/nara/cfr/cfr-table-search.html.

The following additional requirements may apply to this project:

AR-8 Public Health System Reporting Requirements
AR-9 Paperwork Reduction Act Requirements
AR-10 Smoke-Free Workplace Requirements
AR-11 Healthy People 2010
AR-12 Lobbying Restrictions
AR-14 Accounting System Requirements
AR-15 Proof of Non-Profit Status
Additional information on these requirements can be found on the
CDC Web site at the following Internet address: http://www.cdc.gov/od/pgo/funding/ARs.htm
.

VI.3. Reporting Requirements

You must provide CDC with an original, plus two hard copies of the
following reports:
1. Interim progress report, no less than 90 days before the end of
the budget period. The progress report will serve as your non-competing
continuation application, and must contain the following elements:
a. Current Budget Period Activities Objectives.
b. Current Budget Period Financial Progress.
c. New Budget Period Program Proposed Activity Objectives.
d. Budget.
e. Additional Requested Information.
f. Measures of Effectiveness.
2. Financial status report and annual progress report, no more than
90 days after the end of the budget period.
3. Final financial and performance reports, no more than 90 days
after the end of the project period.
These reports must be mailed to the Grants Management or Contract
Specialist listed in the ``Agency Contacts'' section of this
announcement.

VII. Agency Contacts

For general questions about this announcement, contact:

Technical Information Management Section, CDC Procurement and
Grants Office, 2920 Brandywine Road, Atlanta, GA 30341, Telephone:
(770) 488-2700.
For program technical assistance, contact:

For mail service:
4770 Buford Highway, NE., Mailstop K-57, Atlanta, GA 30341-3724,
Telephone: (770) 488-4707, Fax: (770) 488-3230, E-mail: anv1@cdc.gov.
For financial, grants management, or budget assistance, contact:

Glynnis Taylor, Grants Management Specialist, CDC Procurement and
Grants Office, 2920 Brandywine Road, Atlanta, GA 30341, Telephone: 770-
488-2752, E-mail: gld1@cdc.gov.

Dated: March 24, 2004.
Edward Schultz,
Acting Director, Procurement and Grants Office, Centers for Disease
Control and Prevention.
[FR Doc. 04-7026 Filed 3-29-04; 8:45 am]

BILLING CODE 4163-18-P